Literature DB >> 11249095

Secoiridoid constituents from the fruits of Ligustrum lucidum.

Z D He1, H Dong, H X Xu, W C Ye, H D Sun, P P But.   

Abstract

Two secoiridoid glucosides, lucidumosides A and B, as well as six known glucosides, oleoside dimethyl ester, ligustroside, oleuropein, nuezhenide, isonuezhenide, and neonuezhenide, were isolated from the fruits of Ligustrum lucidum. Their structures were elucidated by spectroscopic methods.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11249095     DOI: 10.1016/s0031-9422(00)00406-4

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  5 in total

Review 1.  The advances in research on the pharmacological effects of Fructus Ligustri Lucidi.

Authors:  Zunting Pang; Zhou Zhi-yan; Wei Wang; Yanni Ma; Niu Feng-ju; Xuelan Zhang; Chunchao Han
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

2.  Application of UHPLC-ESI-Q-TOF-MS to Identify Multiple Constituents in Processed Products of the Herbal Medicine Ligustri Lucidi Fructus.

Authors:  Hui Li; Weifeng Yao; Qinan Liu; Jia Xu; Beihua Bao; Mingqiu Shan; Yudan Cao; Fangfang Cheng; Anwei Ding; Li Zhang
Journal:  Molecules       Date:  2017-04-26       Impact factor: 4.411

3.  Anti-Obesity and Gut Microbiota Modulation Effect of Secoiridoid-Enriched Extract from Fraxinus mandshurica Seeds on High-Fat Diet-Fed Mice.

Authors:  Sen Guo; Haoan Zhao; Zhongxiao Ma; Shanshan Zhang; Mingrou Li; Zhaojing Zheng; Xiameng Ren; Chi-Tang Ho; Naisheng Bai
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

4.  Salidroside, 8(E)-Nuezhenide, and Ligustroside from Ligustrum japonicum Fructus Inhibit Expressions of MMP-2 and -9 in HT 1080 Fibrosarcoma.

Authors:  Hojun Kim; Chang-Suk Kong; Youngwan Seo
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

5.  Antioxidant Capacities of Hot Water Extracts and Endopolysaccharides of Selected Chinese Medicinal Fruits.

Authors:  Sang Chul Jeong; Ratna Tulasi; Sundar Rao Koyyalamudi
Journal:  Cancers (Basel)       Date:  2016-03-09       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.